{"DataElement":{"publicId":"13809428","version":"1","preferredName":"Post Surgical Procedure Ipsilateral Node AJCC v8 Pathologic Category","preferredDefinition":"Post-operative, per AJCC 8th edition, pathologic ipsilateral nodes category.","longName":"IPSNDS_AJCCV8_CAT","context":"NRG","contextVersion":"1","DataElementConcept":{"publicId":"13809423","version":"1","preferredName":"Post Surgical Procedure Ipsilateral Node AJCC Cancer Staging Manual 8th Edition Pathologic Examination","preferredDefinition":"Happening at a time subsequent to a reference time; later in time or order._A diagnostic or treatment procedure performed by manual and/or instrumental means, often involving an incision and the removal or replacement of a diseased organ or tissue; of or relating to or involving or used in surgery or requiring or amenable to treatment by surgery._Having to do with the same side of the body._No value exists.:The 8th edition of the criteria developed by the American Joint Committee on Cancer (AJCC), implemented in 2018, used for the classification and staging of neoplastic diseases._An assessment of disease process to include cause, development, and/or structural and functional changes associated with the disease.","longName":"13809426v1.00:13809427v1.00","context":"NRG","contextVersion":"1","ObjectClass":{"publicId":"13809426","version":"1","preferredName":"Post Surgical Procedure Ipsilateral Node","preferredDefinition":"Happening at a time subsequent to a reference time; later in time or order._A diagnostic or treatment procedure performed by manual and/or instrumental means, often involving an incision and the removal or replacement of a diseased organ or tissue; of or relating to or involving or used in surgery or requiring or amenable to treatment by surgery._Having to do with the same side of the body._No value exists.","longName":"C38008:C15329:C25308:C79687","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Post","conceptCode":"C38008","definition":"Happening at a time subsequent to a reference time; later in time or order.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Surgical Procedure","conceptCode":"C15329","definition":"A diagnostic or treatment procedure performed by manual and/or instrumental means, often involving an incision and the removal or replacement of a diseased organ or tissue; of or relating to or involving or used in surgery or requiring or amenable to treatment by surgery.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Ipsilateral","conceptCode":"C25308","definition":"Having to do with the same side of the body.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Node","conceptCode":"C79687","definition":"No value exists.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FD79E5F5-B05D-1C1B-E053-731AD00AFB65","latestVersionIndicator":"Yes","beginDate":"2023-06-06","endDate":null,"createdBy":"TSESU","dateCreated":"2023-06-06","modifiedBy":"TSESU","dateModified":"2023-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"13809427","version":"1","preferredName":"AJCC Cancer Staging Manual 8th Edition Pathologic Examination","preferredDefinition":"The 8th edition of the criteria developed by the American Joint Committee on Cancer (AJCC), implemented in 2018, used for the classification and staging of neoplastic diseases._An assessment of disease process to include cause, development, and/or structural and functional changes associated with the disease.","longName":"C146985:C125006","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"AJCC Cancer Staging Manual 8th Edition","conceptCode":"C146985","definition":"The 8th edition of the criteria developed by the American Joint Committee on Cancer (AJCC), implemented in 2018, used for the classification and staging of neoplastic diseases.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Pathologic Examination","conceptCode":"C125006","definition":"An assessment of disease process to include cause, development, and/or structural and functional changes associated with the disease.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FD79E5F5-B05E-1C1B-E053-731AD00AFB65","latestVersionIndicator":"Yes","beginDate":"2023-06-06","endDate":null,"createdBy":"TSESU","dateCreated":"2023-06-06","modifiedBy":"TSESU","dateModified":"2023-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008525","version":"1","preferredName":"Eligibility","preferredDefinition":"trial-specific criteria that a patient must meet to be enrolled.","longName":"ELIG","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B1EC3968-9F25-305A-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-16","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-16","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FD79B339-2EAB-15F8-E053-731AD00A48E2","latestVersionIndicator":"Yes","beginDate":"2023-06-06","endDate":null,"createdBy":"TSESU","dateCreated":"2023-06-06","modifiedBy":"TSESU","dateModified":"2023-07-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"6005701","version":"1","preferredName":"Breast Carcinoma American Joint Committee on Cancer Edition 8 Pathologic N Category","preferredDefinition":"A pathologic finding about one or more characteristics of breast cancer, following the rules of the TNM AJCC v8 classification system as they pertain to staging of regional lymph nodes._A group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications._One criteria of the TNM staging system.  N refers to the extent of lymph node involvement._A grouping of items based on some commonality or by user defined characteristics.","longName":"6005701v1.0","context":"NCI Standards","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":"3","maxLength":"9","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"pN3a","valueDescription":"Breast Cancer pN3a TNM Finding v8","ValueMeaning":{"publicId":"6005707","version":"1","preferredName":"Breast Cancer pN3a TNM Finding v8","longName":"6005707","preferredDefinition":"Breast cancer with metastases in 10 or more axillary lymph nodes (at least one tumor deposit larger than 2.0 mm); or metastases to the infraclavicular (level III axillary) lymph nodes. (from AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Cancer pN3a TNM Finding v8","conceptCode":"C139442","definition":"Breast cancer with metastases in 10 or more axillary lymph nodes (at least one tumor deposit larger than 2.0 mm); or metastases to the infraclavicular (level III axillary) lymph nodes. (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5BEB4621-5015-4720-E053-F662850AEFBC","latestVersionIndicator":"Yes","beginDate":"2017-10-19","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-10-19","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"5BEB4621-502E-4720-E053-F662850AEFBC","beginDate":"2017-10-19","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-10-19","modifiedBy":"ONEDATA","dateModified":"2017-10-19","deletedIndicator":"No"},{"value":"pN3c","valueDescription":"Breast Cancer pN3c TNM Finding v8","ValueMeaning":{"publicId":"6005703","version":"1","preferredName":"Breast Cancer pN3c TNM Finding v8","longName":"6005703","preferredDefinition":"Breast cancer with metastases in ipsilateral supraclavicular lymph nodes. (from AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Cancer pN3c TNM Finding v8","conceptCode":"C139444","definition":"Breast cancer with metastases in ipsilateral supraclavicular lymph nodes. (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5BEB4621-4FC9-4720-E053-F662850AEFBC","latestVersionIndicator":"Yes","beginDate":"2017-10-19","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-10-19","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"5BEB4621-4FE2-4720-E053-F662850AEFBC","beginDate":"2017-10-19","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-10-19","modifiedBy":"ONEDATA","dateModified":"2017-10-19","deletedIndicator":"No"},{"value":"pN3b","valueDescription":"Breast Cancer pN3b TNM Finding v8","ValueMeaning":{"publicId":"6005705","version":"1","preferredName":"Breast Cancer pN3b TNM Finding v8","longName":"6005705","preferredDefinition":"Breast cancer with pN1a or pN2a in the presence of cN2b (positive internal mammary nodes by imaging); or pN2a in the presence of pN1b. (from AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Cancer pN3b TNM Finding v8","conceptCode":"C139443","definition":"Breast cancer with pN1a or pN2a in the presence of cN2b (positive internal mammary nodes by imaging); or pN2a in the presence of pN1b. (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5BEB4621-4FEF-4720-E053-F662850AEFBC","latestVersionIndicator":"Yes","beginDate":"2017-10-19","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-10-19","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"5BEB4621-5008-4720-E053-F662850AEFBC","beginDate":"2017-10-19","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-10-19","modifiedBy":"ONEDATA","dateModified":"2017-10-19","deletedIndicator":"No"},{"value":"pN3","valueDescription":"Breast Cancer pN3 TNM Finding v8","ValueMeaning":{"publicId":"6005709","version":"1","preferredName":"Breast Cancer pN3 TNM Finding v8","longName":"6005709","preferredDefinition":"Breast cancer with metastases in 10 or more axillary lymph nodes; or in infraclavicular (level III axillary) lymph nodes; or positive ipsilateral internal mammary lymph nodes by imaging in the presence of one or more positive level I, II axillary lymph nodes; or in more than three axillary lymph nodes and micrometastases or macrometastases by sentinel lymph node biopsy in clinically negative ipsilateral internal mammary lymph nodes; or in ipsilateral supraclavicular lymph nodes. (from AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Cancer pN3 TNM Finding v8","conceptCode":"C139441","definition":"Breast cancer with metastases in 10 or more axillary lymph nodes; or in infraclavicular (level III axillary) lymph nodes; or positive ipsilateral internal mammary lymph nodes by imaging in the presence of one or more positive level I, II axillary lymph nodes; or in more than three axillary lymph nodes and micrometastases or macrometastases by sentinel lymph node biopsy in clinically negative ipsilateral internal mammary lymph nodes; or in ipsilateral supraclavicular lymph nodes. (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5BEB4621-503B-4720-E053-F662850AEFBC","latestVersionIndicator":"Yes","beginDate":"2017-10-19","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-10-19","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"5BEB4621-5054-4720-E053-F662850AEFBC","beginDate":"2017-10-19","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-10-19","modifiedBy":"ONEDATA","dateModified":"2017-10-19","deletedIndicator":"No"},{"value":"pN2b","valueDescription":"Breast Cancer pN2b TNM Finding v8","ValueMeaning":{"publicId":"6005711","version":"1","preferredName":"Breast Cancer pN2b TNM Finding v8","longName":"6005711","preferredDefinition":"Breast cancer with metastases in clinically detected internal mammary lymph nodes with or without microscopic confirmation; with pathologically negative axillary nodes. (from AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Cancer pN2b TNM Finding v8","conceptCode":"C139440","definition":"Breast cancer with metastases in clinically detected internal mammary lymph nodes with or without microscopic confirmation; with pathologically negative axillary nodes. (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5BEB4621-5061-4720-E053-F662850AEFBC","latestVersionIndicator":"Yes","beginDate":"2017-10-19","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-10-19","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"5BEB4621-507A-4720-E053-F662850AEFBC","beginDate":"2017-10-19","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-10-19","modifiedBy":"ONEDATA","dateModified":"2017-10-19","deletedIndicator":"No"},{"value":"pN2a","valueDescription":"Breast Cancer pN2a TNM Finding v8","ValueMeaning":{"publicId":"6005713","version":"1","preferredName":"Breast Cancer pN2a TNM Finding v8","longName":"6005713","preferredDefinition":"Breast cancer with metastasis in 4-9 axillary lymph nodes (at least one tumor deposit larger than 2.0 mm). (from AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Cancer pN2a TNM Finding v8","conceptCode":"C139439","definition":"Breast cancer with metastasis in 4-9 axillary lymph nodes (at least one tumor deposit larger than 2.0 mm). (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5BEB4621-5087-4720-E053-F662850AEFBC","latestVersionIndicator":"Yes","beginDate":"2017-10-19","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-10-19","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"5BEB4621-50A0-4720-E053-F662850AEFBC","beginDate":"2017-10-19","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-10-19","modifiedBy":"ONEDATA","dateModified":"2017-10-19","deletedIndicator":"No"},{"value":"pN2","valueDescription":"Breast Cancer pN2 TNM Finding v8","ValueMeaning":{"publicId":"6005715","version":"1","preferredName":"Breast Cancer pN2 TNM Finding v8","longName":"6005715","preferredDefinition":"Breast cancer with metastases in 4-9 axillary lymph nodes; or positive ipsilateral internal mammary lymph nodes by imaging in the absence of axillary lymph node metastases. (from AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Cancer pN2 TNM Finding v8","conceptCode":"C139438","definition":"Breast cancer with metastases in 4-9 axillary lymph nodes; or positive ipsilateral internal mammary lymph nodes by imaging in the absence of axillary lymph node metastases. (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5BEB4621-50AD-4720-E053-F662850AEFBC","latestVersionIndicator":"Yes","beginDate":"2017-10-19","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-10-19","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"5BEB4621-50C6-4720-E053-F662850AEFBC","beginDate":"2017-10-19","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-10-19","modifiedBy":"ONEDATA","dateModified":"2017-10-19","deletedIndicator":"No"},{"value":"pN1mi","valueDescription":"Breast Cancer pN1mi TNM Finding v8","ValueMeaning":{"publicId":"6005717","version":"1","preferredName":"Breast Cancer pN1mi TNM Finding v8","longName":"6005717","preferredDefinition":"Breast cancer with micrometastases (approximately 200 cells, larger than 0.2 mm, but none larger than 2.0 mm). (from AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Cancer pN1mi TNM Finding v8","conceptCode":"C139434","definition":"Breast cancer with micrometastases (approximately 200 cells, larger than 0.2 mm, but none larger than 2.0 mm). (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5BEB4621-50D3-4720-E053-F662850AEFBC","latestVersionIndicator":"Yes","beginDate":"2017-10-19","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-10-19","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"5BEB4621-50EC-4720-E053-F662850AEFBC","beginDate":"2017-10-19","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-10-19","modifiedBy":"ONEDATA","dateModified":"2017-10-19","deletedIndicator":"No"},{"value":"pN1c","valueDescription":"Breast Cancer pN1c TNM Finding v8","ValueMeaning":{"publicId":"6005719","version":"1","preferredName":"Breast Cancer pN1c TNM Finding v8","longName":"6005719","preferredDefinition":"Breast cancer with pN1a and pN1b combined. (from AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Cancer pN1c TNM Finding v8","conceptCode":"C139437","definition":"Breast cancer with pN1a and pN1b combined. (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5BEB4621-50F9-4720-E053-F662850AEFBC","latestVersionIndicator":"Yes","beginDate":"2017-10-19","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-10-19","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"5BEB4621-5112-4720-E053-F662850AEFBC","beginDate":"2017-10-19","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-10-19","modifiedBy":"ONEDATA","dateModified":"2017-10-19","deletedIndicator":"No"},{"value":"pN1b","valueDescription":"Breast Cancer pN1b TNM Finding v8","ValueMeaning":{"publicId":"6005721","version":"1","preferredName":"Breast Cancer pN1b TNM Finding v8","longName":"6005721","preferredDefinition":"Breast cancer with metastases in ipsilateral internal mammary sentinel nodes, excluding ITCs. (from AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Cancer pN1b TNM Finding v8","conceptCode":"C139436","definition":"Breast cancer with metastases in ipsilateral internal mammary sentinel nodes, excluding ITCs. (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5BEB4621-511F-4720-E053-F662850AEFBC","latestVersionIndicator":"Yes","beginDate":"2017-10-19","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-10-19","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"5BEB4621-5138-4720-E053-F662850AEFBC","beginDate":"2017-10-19","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-10-19","modifiedBy":"ONEDATA","dateModified":"2017-10-19","deletedIndicator":"No"},{"value":"pN1a","valueDescription":"Breast Cancer pN1a TNM Finding v8","ValueMeaning":{"publicId":"6005723","version":"1","preferredName":"Breast Cancer pN1a TNM Finding v8","longName":"6005723","preferredDefinition":"Breast cancer with metastases in 1-3 axillary lymph nodes, at least one metastasis larger than 2.0 mm. (from AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Cancer pN1a TNM Finding v8","conceptCode":"C139435","definition":"Breast cancer with metastases in 1-3 axillary lymph nodes, at least one metastasis larger than 2.0 mm. (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5BEB4621-5145-4720-E053-F662850AEFBC","latestVersionIndicator":"Yes","beginDate":"2017-10-19","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-10-19","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"5BEB4621-515E-4720-E053-F662850AEFBC","beginDate":"2017-10-19","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-10-19","modifiedBy":"ONEDATA","dateModified":"2017-10-19","deletedIndicator":"No"},{"value":"pN1","valueDescription":"Breast Cancer pN1 TNM Finding v8","ValueMeaning":{"publicId":"6005725","version":"1","preferredName":"Breast Cancer pN1 TNM Finding v8","longName":"6005725","preferredDefinition":"Breast cancer with micrometastases; or metastases in 1-3 axillary lymph nodes; and/or clinically negative internal mammary nodes with micrometastases or macrometastases by sentinel lymph node biopsy. (from AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Cancer pN1 TNM Finding v8","conceptCode":"C139433","definition":"Breast cancer with micrometastases; or metastases in 1-3 axillary lymph nodes; and/or clinically negative internal mammary nodes with micrometastases or macrometastases by sentinel lymph node biopsy. (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5BEB4621-516B-4720-E053-F662850AEFBC","latestVersionIndicator":"Yes","beginDate":"2017-10-19","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-10-19","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"5BEB4621-5184-4720-E053-F662850AEFBC","beginDate":"2017-10-19","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-10-19","modifiedBy":"ONEDATA","dateModified":"2017-10-19","deletedIndicator":"No"},{"value":"pN0(mol+)","valueDescription":"Breast Cancer pN0(mol+) TNM Finding v8","ValueMeaning":{"publicId":"6005727","version":"1","preferredName":"Breast Cancer pN0(mol+) TNM Finding v8","longName":"6005727","preferredDefinition":"Breast cancer with positive molecular findings by reverse transcriptase polymerase chain reaction (RT-PCR); no ITCs detected. (from AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Cancer pN0(mol+) TNM Finding v8","conceptCode":"C139432","definition":"Breast cancer with positive molecular findings by reverse transcriptase polymerase chain reaction (RT-PCR); no ITCs detected. (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5BEB4621-5191-4720-E053-F662850AEFBC","latestVersionIndicator":"Yes","beginDate":"2017-10-19","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-10-19","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"5BEB4621-51AA-4720-E053-F662850AEFBC","beginDate":"2017-10-19","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-10-19","modifiedBy":"ONEDATA","dateModified":"2017-10-19","deletedIndicator":"No"},{"value":"pN0(i+)","valueDescription":"Breast Cancer pN0(i+) TNM Finding v8","ValueMeaning":{"publicId":"6005729","version":"1","preferredName":"Breast Cancer pN0(i+) TNM Finding v8","longName":"6005729","preferredDefinition":"Breast cancer with ITCs only (malignant cell clusters no larger than 0.2 mm) in regional lymph node(s). (from AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Cancer pN0(i+) TNM Finding v8","conceptCode":"C139431","definition":"Breast cancer with ITCs only (malignant cell clusters no larger than 0.2 mm) in regional lymph node(s). (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5BEB4621-51B7-4720-E053-F662850AEFBC","latestVersionIndicator":"Yes","beginDate":"2017-10-19","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-10-19","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"5BEB4621-51D0-4720-E053-F662850AEFBC","beginDate":"2017-10-19","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-10-19","modifiedBy":"ONEDATA","dateModified":"2017-10-19","deletedIndicator":"No"},{"value":"pN0","valueDescription":"Breast Cancer pN0 TNM Finding v8","ValueMeaning":{"publicId":"6005731","version":"1","preferredName":"Breast Cancer pN0 TNM Finding v8","longName":"6005731","preferredDefinition":"Breast cancer in which no regional lymph node metastasis is identified or isolated tumor cell clusters (ITCs) are identified only. (from AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Cancer pN0 TNM Finding v8","conceptCode":"C139430","definition":"Breast cancer in which no regional lymph node metastasis is identified or isolated tumor cell clusters (ITCs) are identified only. (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5BEB4621-51DD-4720-E053-F662850AEFBC","latestVersionIndicator":"Yes","beginDate":"2017-10-19","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-10-19","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"5BEB4621-51F6-4720-E053-F662850AEFBC","beginDate":"2017-10-19","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-10-19","modifiedBy":"ONEDATA","dateModified":"2017-10-19","deletedIndicator":"No"},{"value":"pNX","valueDescription":"Breast Cancer pNX TNM Finding v8","ValueMeaning":{"publicId":"6005733","version":"1","preferredName":"Breast Cancer pNX TNM Finding v8","longName":"6005733","preferredDefinition":"Breast cancer in which regional lymph nodes cannot be assessed (e.g., not removed for pathological study or previously removed).  (from AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Cancer pNX TNM Finding v8","conceptCode":"C139429","definition":"Breast cancer in which regional lymph nodes cannot be assessed (e.g., not removed for pathological study or previously removed).  (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5BEB4621-5203-4720-E053-F662850AEFBC","latestVersionIndicator":"Yes","beginDate":"2017-10-19","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-10-19","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"5BEB4621-521C-4720-E053-F662850AEFBC","beginDate":"2017-10-19","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-10-19","modifiedBy":"ONEDATA","dateModified":"2017-10-19","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"6356800","version":"1","preferredName":"Breast Cancer Pathologic Regional Lymph Nodes TNM Finding v8 American Joint Committee on Cancer N Category Category","preferredDefinition":"A pathologic finding about one or more characteristics of breast cancer, following the rules of the TNM AJCC v8 classification system as they pertain to staging of regional lymph nodes.:A group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications.:One criteria of the TNM staging system. N refers to the extent of lymph node involvement.:A grouping of items based on some commonality or by user defined characteristics.","longName":"C139428:C39315:C25580:C25372","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Cancer Pathologic Regional Lymph Nodes TNM Finding v8","conceptCode":"C139428","definition":"A pathologic finding about one or more characteristics of breast cancer, following the rules of the TNM AJCC v8 classification system as they pertain to staging of regional lymph nodes.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"American Joint Committee on Cancer","conceptCode":"C39315","definition":"A group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"N Category","conceptCode":"C25580","definition":"One criteria of the TNM staging system. N refers to the extent of lymph node involvement.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Category","conceptCode":"C25372","definition":"A grouping of items based on some commonality or by user defined characteristics.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"71357C17-2882-10C0-E053-F662850A51FC","latestVersionIndicator":"Yes","beginDate":"2018-07-17","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-07-17","modifiedBy":"ONEDATA","dateModified":"2018-07-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"AJCC Based:Staging Criteria Based on American Joint Committee on Cancer System","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"5BEA94F0-EE79-3BA5-E053-F662850AA77F","latestVersionIndicator":"Yes","beginDate":"2017-10-19","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-10-19","modifiedBy":"COLBERTM","dateModified":"2021-12-01","changeDescription":"5-3-19 released; tmt. 7/17/18 tt updated/Focus Group recommendations.  11/17/17 tt associated with CS/CSI. 10/19/1t tt created for standardization; supercedes VD 3655846.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[],"ReferenceDocuments":[{"name":"PQT","type":"Preferred Question Text","description":"Postoperatively, according to AJCC 8th edition, by pathologic evaluation, the ipsilateral nodes are:","url":null,"context":"NRG"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FD7A16AE-CAF6-22CE-E053-731AD00A636D","latestVersionIndicator":"Yes","beginDate":"2023-06-06","endDate":null,"createdBy":"TSESU","dateCreated":"2023-06-06","modifiedBy":"TSESU","dateModified":"2023-07-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}